On Dec 13, all the VPs who responsible for drug safety evaluation from Shanghai gathered together at Pudong to attend the annual GLP meeting held by Medicion Preclinical Research (Shanghai) LLC. During the meeting, every VP shared their own thoughts and discussed the future trends of drug safety evaluations and the policies of biotechnology industry in China.
Medicilon successfully passed the US FDA GLP on-site inspection